Cargando…

Research in haematological cancers: What do patients in the Netherlands prioritise?

INTRODUCTION: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Schölvinck, Anne‐Floor M., de Graaff, Bert M. B., van den Beld, Mechteld J., Broerse, Jacqueline E. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285610/
https://www.ncbi.nlm.nih.gov/pubmed/30675743
http://dx.doi.org/10.1111/ecc.12989
_version_ 1784747823870246912
author Schölvinck, Anne‐Floor M.
de Graaff, Bert M. B.
van den Beld, Mechteld J.
Broerse, Jacqueline E. W.
author_facet Schölvinck, Anne‐Floor M.
de Graaff, Bert M. B.
van den Beld, Mechteld J.
Broerse, Jacqueline E. W.
author_sort Schölvinck, Anne‐Floor M.
collection PubMed
description INTRODUCTION: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell transplantation. METHODS: A mixed‐method participatory research approach (the Dialogue Model) was applied, including interviews (n = 19), four focus group discussions (n = 27), a questionnaire (n = 146) and a stakeholder dialogue meeting (n = 30) with patients in the Netherlands. RESULTS: Patients’ physical discomfort, psychosocial issues, problems with the healthcare system and policy issues were highlighted. Respondents prioritise research aimed at factors potentially influencing survival, such as lifestyle, and research aimed at improving patients’ quality of life, for example improving memory and concentration problems. Topics also focused on physical discomfort, causal mechanisms, and healthcare organisation and policies. Research of a social scientific character is underrepresented, and as such, patients’ everyday problems are not all directly reflected in the research agenda. CONCLUSIONS: Our findings indicate that patients, besides emphasising the importance of improving survival, have a clear desire to increase control over their lives.
format Online
Article
Text
id pubmed-9285610
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92856102022-07-18 Research in haematological cancers: What do patients in the Netherlands prioritise? Schölvinck, Anne‐Floor M. de Graaff, Bert M. B. van den Beld, Mechteld J. Broerse, Jacqueline E. W. Eur J Cancer Care (Engl) Original Articles INTRODUCTION: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell transplantation. METHODS: A mixed‐method participatory research approach (the Dialogue Model) was applied, including interviews (n = 19), four focus group discussions (n = 27), a questionnaire (n = 146) and a stakeholder dialogue meeting (n = 30) with patients in the Netherlands. RESULTS: Patients’ physical discomfort, psychosocial issues, problems with the healthcare system and policy issues were highlighted. Respondents prioritise research aimed at factors potentially influencing survival, such as lifestyle, and research aimed at improving patients’ quality of life, for example improving memory and concentration problems. Topics also focused on physical discomfort, causal mechanisms, and healthcare organisation and policies. Research of a social scientific character is underrepresented, and as such, patients’ everyday problems are not all directly reflected in the research agenda. CONCLUSIONS: Our findings indicate that patients, besides emphasising the importance of improving survival, have a clear desire to increase control over their lives. John Wiley and Sons Inc. 2019-01-23 2019-03 /pmc/articles/PMC9285610/ /pubmed/30675743 http://dx.doi.org/10.1111/ecc.12989 Text en © 2019 The Authors. European Journal of Cancer Care Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Schölvinck, Anne‐Floor M.
de Graaff, Bert M. B.
van den Beld, Mechteld J.
Broerse, Jacqueline E. W.
Research in haematological cancers: What do patients in the Netherlands prioritise?
title Research in haematological cancers: What do patients in the Netherlands prioritise?
title_full Research in haematological cancers: What do patients in the Netherlands prioritise?
title_fullStr Research in haematological cancers: What do patients in the Netherlands prioritise?
title_full_unstemmed Research in haematological cancers: What do patients in the Netherlands prioritise?
title_short Research in haematological cancers: What do patients in the Netherlands prioritise?
title_sort research in haematological cancers: what do patients in the netherlands prioritise?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285610/
https://www.ncbi.nlm.nih.gov/pubmed/30675743
http://dx.doi.org/10.1111/ecc.12989
work_keys_str_mv AT scholvinckannefloorm researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise
AT degraaffbertmb researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise
AT vandenbeldmechteldj researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise
AT broersejacquelineew researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise